|
Issue identified during product analysis.H3: device evaluation summary: medtronic conducted an investigation based upon all information received.It was reported that this ht70 ventilator would not power on.The device was available for evaluation.The service personnel (sp) inspected the ventilator, confirmed the reported issue, and replaced the control board.The device passed all the required tests and calibrations as per the manufacturer's specifications at the time of service and was in working condition.One control board was received for failure analysis.Visual inspection found thermal damage at capacitor c92.The device was further investigated and found that capacitor c92 had internally shorted.This failure mode of c92 during use would lead to a loss of ventilation if the fault were to occur during patient use.It was also observed that the q58 and c262 to be displaced due to physical contact.The cause of the event was isolated to damaged c92 in control board.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it has met all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|